Lilia Matei
Overview
Explore the profile of Lilia Matei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
435
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurban P, Mambet C, Botezatu A, Necula L, Matei L, Neagu A, et al.
Am J Hematol
. 2024 Oct;
100(1):168-171.
PMID: 39425629
No abstract available.
2.
Grecu L, Pavel-Tanasa M, Matei L, Sultana C, Ruta S, Grecu R, et al.
Pathogens
. 2024 Sep;
13(9).
PMID: 39338984
The hepatitis D virus (HDV) superinfection of individuals with chronic hepatitis B virus (HBV) infection causes severe liver damage and the poorest long-term prognosis among viral hepatitis. This is attributed...
3.
Gurban P, Mambet C, Botezatu A, Necula L, Matei L, Neagu A, et al.
J Cell Mol Med
. 2024 Aug;
28(16):e70024.
PMID: 39183370
BCR::ABL1-negative myeloproliferative neoplasms (MPNs) are clonal haematopoietic stem cell disorders characterized by specific driver mutations and an increased risk of both macrothrombosis and microthrombosis. Serotonin receptor type 1B (HTR1B) was...
4.
Bleotu C, Matei L, Dragu L, Necula L, Pitica I, Chivu-Economescu M, et al.
Microorganisms
. 2024 Jul;
12(7).
PMID: 39065197
Wastewater monitoring provides essential information about water quality and the degree of contamination. Monitoring these waters helps identify and manage risks to public health, prevent the spread of disease, and...
5.
Ruta S, Popescu C, Matei L, Grancea C, Paun A, Oprea C, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932392
Immunosuppressed individuals, such as people living with HIV (PLWH), remain vulnerable to severe COVID-19. We analyzed the persistence of specific SARS-CoV-2 humoral and cellular immune responses in a retrospective, cross-sectional...
6.
Iancu I, Diaconu C, Plesa A, Fudulu A, Albulescu A, Neagu A, et al.
J Cell Mol Med
. 2024 Mar;
28(7):e18226.
PMID: 38501860
More than 3 years after the start of SARS-CoV-2 pandemic, the molecular mechanisms behind the viral pathogenesis are still not completely understood. Long non-coding RNAs (lncRNAs), well-known players in viral...
7.
Grecu L, Sultana C, Pavel-Tanasa M, Ruta S, Chivu-Economescu M, Matei L, et al.
Microorganisms
. 2023 Dec;
11(12).
PMID: 38138039
Approximately 62-72 million people are infected worldwide with HDV. Patients with chronic hepatitis D (CHD) have a higher risk of developing cirrhosis or hepatocellular carcinoma (HCC) and an increased mortality...
8.
Gurban P, Mambet C, Botezatu A, Necula L, Neagu A, Matei L, et al.
Front Oncol
. 2023 Oct;
13:1266996.
PMID: 37841434
Somatic frameshift mutations in exon 9 of calreticulin () gene are recognized as disease drivers in primary myelofibrosis (PMF), one of the three classical Philadelphia-negative myeloproliferative neoplasms (MPNs). Type 1/type...
9.
Chivu-Economescu M, Herlea V, Dima S, Sorop A, Pechianu C, Procop A, et al.
Gastric Cancer
. 2023 Sep;
26(6):934-946.
PMID: 37668884
Background: In this study, we compared programmed death-ligand 1 (PD-L1) expression in primary tissue samples and its soluble form (sPD-L1) concentration in matched preoperative plasma samples from gastric cancer patients...
10.
Duda D, Dima S, Sorop A, Kitahara S, Setia N, Chivu-Economescu M, et al.
Res Sq
. 2023 Aug;
PMID: 37577519
With approximately one million diagnosed cases and over 700,000 deaths recorded annually, gastric cancer (GC) is the third most common cause of cancer-related deaths worldwide. GC is a heterogeneous tumor....